Achieving the energy transition is at the top of the political agenda, at least in Germany. One of the biggest challenges here is to achieve climate neutrality in the transport sector by 2045. After all, according to the Federal Environment Agency, the sector is responsible for around 20% of total greenhouse gas emissions. In contrast to the energy sector or industry, CO2 emissions have even increased since 1990 despite the development of more efficient vehicles. Therefore, significant changes are needed to reverse emissions growth and meet new mandates while meeting the increasing demand for mobility and freight. In the passenger vehicle sector, both the automotive industry and policymakers are focusing on battery technology. In contrast, hydrogen fuel cell technology offers clear advantages over electric propulsion for commercial vehicles, which are responsible for about 35% of transportation emissions. First Hydrogen aims to become the leading designer and manufacturer of zero-emission, long-range hydrogen-powered vehicles in the UK, EU and North America. The conditions for this are favorable. That is why we are taking a closer look at this exciting market.
Vaccines against cancer and improved transport of active substances into tumor cells - the Canadian biotech company Defence Therapeutics promises no less with its patented technology. In the next six months, Defence Therapeutics intends to prove that its vaccines are safe in Phase 1 trials. That finding could be a liberating blow for the company. Read our research to find out what else makes the biotech tick and why the stock is entering an exciting phase.
We are in the middle of the fourth Corona wave. Uncertainty about the effects of the new mutation Omicron recently weighed on the mood on the stock markets. Skeptical statements by Moderna's CEO on the controllability of the new variant are irritating, especially since BioNTech has an entirely different view of the situation. This uncertainty hit Valneva, a new Corona vaccine supplier looking to throw its hat into the ring, particularly hard. Shares in the French-Austrian biotech company lost significant ground after - at first glance - disappointing results on the suitability of their vaccine as a booster vaccine. Valneva's approach with so-called dead vaccines contrasts with vector or mRNA vaccines, which are currently exclusively used. Dead vaccines have been used in medicine for a long time (tetanus, pertussis, diphtheria, influenza vaccination) and are considered well-established. The new vaccine category could thus persuade vaccine skeptics to get vaccinated. Approval of the Valneva vaccine in the EU has been applied for, and initial orders have been received. The green light from the health authorities should come soon. US-based Novavax should be even quicker to market with a protein vaccine. What chances do the newcomers have? Are they the new top dogs?
Early-stage biotech companies rarely provide detailed insights into their universe. It is not surprising, as the market for diagnostics in the context of Covid-19, in particular, is highly competitive. The company featured here, XPhyto Therapeutics Corp. is reportedly preparing to take off in the coming weeks and months in not one but two of three business areas. Specifically, it is looking at precise and rapid PCR testing that does not require a traditional lab and promises results in 25 minutes. But it is also about testing methods for other typical diseases. Regarding medications, the provider presented here is working on procedures to improve their effect on patients and even produce them more cheaply. The following report on biotech summarizes which company XPhyto wants to catch up with in the long term and the market potential. An insight into a very dynamic market.
The shortage of critical metals could lead to a huge problem for high-tech industries. The leading producer for many industrial metals is China, as in the case of tungsten. Although the Middle Kingdom dominates the tungsten market and has numerous mines in operation, imports to China recently increased by a full 20% YOY. This is one of the best leading indicators for a new market scenario because, after all, China has controlled the market so far. Now the country even has to buy in the already empty international market. A demand overhang could not be clearer. Almonty Industries can cover an important share of global tungsten demand in the medium term.
For years, the climate and energy turnaround has determined events in the economy. Since the coalition agreement of the upcoming German government was presented, it has become clear that sustainability and renewable energy sources will become even more important in the future. Reason enough to take a closer look at the shares of wind turbine manufacturer Nordex. Can shareholders now hope for a significant boost in demand? What role do sluggish approval procedures play in operational progress on the German market? Which global markets are gaining in importance? How can we succeed in boosting the still relatively weak margins in times of raw material shortages? Answers to these and other questions are in the following article.
Stock market trading experienced a real boom in 2020 as a result of the Corona lockdowns. A new group of investors, primarily from "Generation Z", took a liking to buying and selling company shares. Rising customer and transaction numbers helped online brokers to achieve record sales and profits. The neobrokers in particular, which appeal to tech-savvy customers with simple trading via smartphone, have already achieved valuations in the billions in various capital rounds. In comparison, wallstreet:online AG with its Smartbroker lags significantly behind newcomers to the industry such as Trade Republic & Co. in terms of perception and valuation. And this, although the existing assets show a different picture. We take a look at the situation.
In view of high inflation, which is certain to continue, there are good opportunities for precious metal prices to rise in the medium term. As a rule, gold stocks exhibit a high sensitivity to gold price developments over longer periods. High-opportunity stocks are particularly rare. The Canadians presented here hold 45% in the Barsele Gold Project in Sweden. Even though a takeover failed for the time being, a closing can apparently be expected next year. That would lead to a rapid re-rating of the stock. The project currently has a 2019 resource estimate of 2.4 million ounces of gold combined with the potential to expand this to 3.5 million ounces in the near future. Analysts already attest to the stock's significant upside potential. The project size also makes the Canadians a takeover candidate. We look at the details.
Visionary technologies have a significant impact on how we will live and work in the future. Digitization is shaping our daily interactions with friends, partners and even family. In this context, the Corona pandemic acted as a catalyst for spatially independent working. Lockdown measures and the relocation of the workplace to the home created an entirely new situation for society. A new work situation that started with mobile working in the years before Corona has now experienced a significant acceleration. In addition to companies such as Zoom or Slack, TeamViewer also benefited with its comprehensive solution for remote access, remote control and remote maintenance. As a result of the rapid growth, the Göppingen-based software company invested massively in personnel and brand development. Now, the trend is slowing down, and TeamViewer is facing one of the most important phases in its fifteen-year company history. Our analysis.
Inflation is on everyone's lips. In addition, interest rates are low, so investors from the major economies of Europe and North America are currently suffering a loss of purchasing power of around 4% to 6% per year. A proven strategy for asset protection over a more extended period of time is to invest in tangible assets such as shares, real estate or precious metals. In addition to physical investments in gold, gold shares are also an option. With these, the precious metal price increase can usually be leveraged. This connection is especially true for exploration companies. Therefore, rising gold prices and an upcoming resource estimate are good reasons to take a closer look at Desert Gold Ventures. The Company could become a desirable takeover candidate in the future.